|
|
|
Volumn 103, Issue 13, 1996, Pages 80-86
|
|
Oestrogen replacement therapy and Alzheimer's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONJUGATED ESTROGEN;
ESTRADIOL;
ESTROGEN;
GESTAGEN;
MEDROXYPROGESTERONE ACETATE;
NALMEFENE;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG FORMULATION;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
MAJOR CLINICAL STUDY;
MENOPAUSE;
PRIORITY JOURNAL;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
CASE-CONTROL STUDIES;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HUMANS;
MIDDLE AGED;
NEUROTRANSMITTER AGENTS;
PROGESTINS;
|
|
EID: 0029896796
PISSN: 01407686
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (60)
|
|
References (0)
|
